<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
<head>
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
</head>
<body text="#000000" bgcolor="#ffffff">
i'm sorry. i amend my previous statements. trademarks are also
becoming an increasingly empoverished battle ground, as major
enterprises have realised there are more efficient ways of
mistreating consumers and fellow enterprises. ref.<br>
<br>
-------- Original Message --------
<table class="moz-email-headers-table" border="0" cellpadding="0"
cellspacing="0">
<tbody>
<tr>
<th nowrap="nowrap" valign="BASELINE" align="RIGHT">Subject: </th>
<td>IP-Watch: Genetics Company Myriad May Shift From Patents
To Proprietary Data</td>
</tr>
<tr>
<th nowrap="nowrap" valign="BASELINE" align="RIGHT">Date: </th>
<td>Thu, 3 Mar 2011 13:18:31 +0100</td>
</tr>
<tr>
<th nowrap="nowrap" valign="BASELINE" align="RIGHT">From: </th>
<td>Intellectual Property Watch <a class="moz-txt-link-rfc2396E" href="mailto:info@ip-watch.ch"><info@ip-watch.ch></a></td>
</tr>
<tr>
<th nowrap="nowrap" valign="BASELINE" align="RIGHT">To: </th>
<td><a class="moz-txt-link-abbreviated" href="mailto:teirdes@gmail.com">teirdes@gmail.com</a></td>
</tr>
</tbody>
</table>
<br>
<br>
This is the post digest for <a moz-do-not-send="true"
href="mailto:teirdes@gmail.com">teirdes@gmail.com</a> sent by the
Intellectual Property Watch website.<br>
<br>
********************************************************************************************************<br>
<br>
March 03, 2011. Genetics Company Myriad May Shift From Patents To
Proprietary Data<br>
<br>
Myriad Genetics, a United States-based biotechnology company with
exclusive patent rights over a key breast cancer diagnostic test in
the US, may shift its patent strategy from its inventions to
protecting its data in the face of drawn out litigation and upcoming
competition, an industry journal has reported. <br>
<br>
Link to the article: <a moz-do-not-send="true"
href="http://www.ip-watch.org/weblog/?p=14644&utm_source=post&utm_medium=email&utm_campaign=alerts">http://www.ip-watch.org/weblog/?p=14644&utm_source=post&utm_medium=email&utm_campaign=alerts</a><br>
<br>
----------------------------------------------------------------------------------------------<br>
<br>
Become an Intellectual Property Watch subscriber to receive all the
news stories, briefs,
and the latest on people in the IP policy community not available
elsewhere on the IPW website.<br>
Click here for details:<br>
<a moz-do-not-send="true"
href="http://www.ip-watch.org/user/registration">http://www.ip-watch.org/user/registration</a><br>
<br>
----------------------------------------------------------------------------------------------<br>
<br>
You are signed up to receive these notifications.<br>
<br>
You may change the frequency of your email alerts to immediate,
daily, weekly or
monthly and may choose the topics you wish to be notified about.<br>
If you would like to modify the settings of your subscription or to
be removed, visit the url below:<br>
<a moz-do-not-send="true"
href="http://www.ip-watch.org/user/manage/u/43026488b2b34fc80ecdbea29a2cec8a">http://www.ip-watch.org/user/manage/u/43026488b2b34fc80ecdbea29a2cec8a</a>
</body>
</html>